Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Mar 6;82(7):1261–1265. doi: 10.1054/bjoc.1999.1088

Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma

J D Robertson 1, K Nagesh 1, S N Jowitt 1, M Dougal 1, H Anderson 1, K Mutton 2, M Zambon 3, J H Scarffe 1
PMCID: PMC2374477  PMID: 10755398

Abstract

Vaccination against influenza and Streptococcus pneumoniae is recommended for elderly and immunocompromised individuals. However, there is little information concerning the efficacy of vaccination in specific groups of patients. In this study, 52 patients underwent vaccination against influenza, S. pneumoniae and Haemophilus influenzae type b (Hib) as they attended hospital outpatient clinics. Serum was analysed prior to vaccination and 4–6 weeks afterwards. Antibody titres against S. pneumoniae and Hib were compared with reference values corresponding to the geometric mean titres of a healthy UK population. For influenza vaccination, haemagglutination inhibition (HI) titres were measured against three inactivated strains; a titre of ≥ 1/40 was considered protective. No patient had protective titres to all three antigens prior to vaccination and 41 patients (85%) had titres < 1/40 to all 3 strains. Post vaccination only 9/48 patients (19%) achieved protective antibody titres. Resistance to S. pneumoniae and response to Pneumovax II was also poor: prevaccination, 45 patients (93%) had suboptimal antibody titres and in 26/43 patients (61%) titres remained low post vaccination. Resistance to Hib and response to vaccination was comparable with the healthy adult UK population. These results question the practice of routine influenza and pneumococcal vaccination in myeloma patients. © 2000 Cancer Research Campaign

Keywords: myeloma, influenza, Streptococcus pneumoniae, Haemophilus influenzae, vaccination

Full Text

The Full Text of this article is available as a PDF (61.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Admon D., Engelhard D., Strauss N., Goldman N., Zakay-Rones Z. Antibody response to influenza immunization in patients after heart transplantation. Vaccine. 1997 Oct;15(14):1518–1522. doi: 10.1016/s0264-410x(97)00193-x. [DOI] [PubMed] [Google Scholar]
  2. Ahmed A. E., Nicholson K. G., Nguyen-Van-Tam J. S. Reduction in mortality associated with influenza vaccine during 1989-90 epidemic. Lancet. 1995 Sep 2;346(8975):591–595. doi: 10.1016/s0140-6736(95)91434-x. [DOI] [PubMed] [Google Scholar]
  3. Anderson H., Petrie K., Berrisford C., Charlett A., Thatcher N., Zambon M. Seroconversion after influenza vaccination in patients with lung cancer. Br J Cancer. 1999 Apr;80(1-2):219–220. doi: 10.1038/sj.bjc.6690342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brydak L. B., Rokicka-Milewska R., Machała M., Jackowska T., Sikorska-Fic B. Immunogenicity of subunit trivalent influenza vaccine in children with acute lymphoblastic leukemia. Pediatr Infect Dis J. 1998 Feb;17(2):125–129. doi: 10.1097/00006454-199802000-00009. [DOI] [PubMed] [Google Scholar]
  5. Chakraverty P. Antigenic relationship between influenza B viruses. Bull World Health Organ. 1971;45(6):755–766. [PMC free article] [PubMed] [Google Scholar]
  6. Dedman D. J., Zambon M., Buynder P. V., Fleming D. M., Watson J. M., Joseph C. A. Influenza surveillance in England and Wales: October 1997 to June 1998. Commun Dis Public Health. 1998 Dec;1(4):244–251. [PubMed] [Google Scholar]
  7. Deresinski S. C., Stevens D. A. Disseminated herpes simplex in untreated multiple myeloma. Paradox of present concepts of immune defects. Oncology. 1974;30(4):318–323. doi: 10.1159/000224970. [DOI] [PubMed] [Google Scholar]
  8. FAHEY J. L., SCOGGINS R., UTZ J. P., SZWED C. F. INFECTION, ANTIBODY RESPONSE AND GAMMA GLOBULIN COMPONENTS IN MULTIPLE MYELOMA AND MACROGLOBULINEMIA. Am J Med. 1963 Nov;35:698–707. doi: 10.1016/0002-9343(63)90140-2. [DOI] [PubMed] [Google Scholar]
  9. Gribabis D. A., Panayiotidis P., Boussiotis V. A., Hannoun C., Pangalis G. A. Influenza virus vaccine in B-cell chronic lymphocytic leukaemia patients. Acta Haematol. 1994;91(3):115–118. doi: 10.1159/000204315. [DOI] [PubMed] [Google Scholar]
  10. Gross P. A., Quinnan G. V., Jr, Weksler M. E., Setia U., Douglas R. G., Jr Relation of chronic disease and immune response to influenza vaccine in the elderly. Vaccine. 1989 Aug;7(4):303–308. doi: 10.1016/0264-410x(89)90190-4. [DOI] [PubMed] [Google Scholar]
  11. Hobson D., Curry R. L., Beare A. S., Ward-Gardner A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) 1972 Dec;70(4):767–777. doi: 10.1017/s0022172400022610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Honkanen P. O., Keistinen T., Kivelä S. L. Reactions following administration of influenza vaccine alone or with pneumococcal vaccine to the elderly. Arch Intern Med. 1996 Jan 22;156(2):205–208. [PubMed] [Google Scholar]
  13. Iorio A. M., Alatri A., Francisci D., Preziosi R., Neri M., Donatelli I., Castrucci M. R., Biasio L. R., Tascini C., Iapoce R. Immunogenicity of influenza vaccine (1993-94 winter season) in HIV-seropositive and -seronegative ex-intravenous drug users. Vaccine. 1997 Jan;15(1):97–102. doi: 10.1016/s0264-410x(96)00057-6. [DOI] [PubMed] [Google Scholar]
  14. Jackson L. A., Benson P., Sneller V. P., Butler J. C., Thompson R. S., Chen R. T., Lewis L. S., Carlone G., DeStefano F., Holder P. Safety of revaccination with pneumococcal polysaccharide vaccine. JAMA. 1999 Jan 20;281(3):243–248. doi: 10.1001/jama.281.3.243. [DOI] [PubMed] [Google Scholar]
  15. Luque R., Brieva J. A., Moreno A., Manzanal A., Escribano L., Villarrubia J., Velasco J. L., López-Jiménez J., Cerveró C., Otero M. J. Normal and clonal B lineage cells can be distinguished by their differential expression of B cell antigens and adhesion molecules in peripheral blood from multiple myeloma (MM) patients--diagnostic and clinical implications. Clin Exp Immunol. 1998 Jun;112(3):410–418. doi: 10.1046/j.1365-2249.1998.00600.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lyall E. G., Charlett A., Watkins P., Zambon M. Response to influenza virus vaccination in vertical HIV infection. Arch Dis Child. 1997 Mar;76(3):215–218. doi: 10.1136/adc.76.3.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Miotti P. G., Nelson K. E., Dallabetta G. A., Farzadegan H., Margolick J., Clements M. L. The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccine. JAMA. 1989 Aug 11;262(6):779–783. [PubMed] [Google Scholar]
  18. Musto P., Carotenuto M. Vaccination against influenza in multiple myeloma. Br J Haematol. 1997 May;97(2):505–506. [PubMed] [Google Scholar]
  19. Norden C. W. Infections in patients with multiple myeloma. Arch Intern Med. 1980 Sep;140(9):1150–1151. [PubMed] [Google Scholar]
  20. Parkkali T., Käyhty H., Ruutu T., Volin L., Eskola J., Ruutu P. A comparison of early and late vaccination with Haemophilus influenzae type b conjugate and pneumococcal polysaccharide vaccines after allogeneic BMT. Bone Marrow Transplant. 1996 Nov;18(5):961–967. [PubMed] [Google Scholar]
  21. Ringdén O. Allogeneic bone marrow transplantation for hematological malignancies--controversies and recent advances. Acta Oncol. 1997;36(6):549–564. doi: 10.3109/02841869709001316. [DOI] [PubMed] [Google Scholar]
  22. Savage D. G., Lindenbaum J., Garrett T. J. Biphasic pattern of bacterial infection in multiple myeloma. Ann Intern Med. 1982 Jan;96(1):47–50. doi: 10.7326/0003-4819-96-1-47. [DOI] [PubMed] [Google Scholar]
  23. Sullivan K. M., Monto A. S., Foster D. A. Antibody response to inactivated influenza vaccines of various antigenic concentrations. J Infect Dis. 1990 Feb;161(2):333–335. doi: 10.1093/infdis/161.2.333. [DOI] [PubMed] [Google Scholar]
  24. Vladutiu A. O. The severe combined immunodeficient (SCID) mouse as a model for the study of autoimmune diseases. Clin Exp Immunol. 1993 Jul;93(1):1–8. doi: 10.1111/j.1365-2249.1993.tb06488.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Zuckerman M. A., Wood J., Chakraverty P., Taylor J., Heath A. B., Oxford J. S. Serological responses in volunteers to inactivated trivalent subunit influenza vaccine: antibody reactivity with epidemic influenza A and B strains and evidence of a rapid immune response. J Med Virol. 1991 Feb;33(2):133–137. doi: 10.1002/jmv.1890330213. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES